Type 2 Diabetes and its Treatment with Linagliptin are both Associated with Elevated Mortality in Bullous Pemphigoid

被引：1
|
作者：
Leisti, Paivi [1 ,2 ]
Pankakoski, Anna [3 ,4 ]
Jokelainen, Jari [5 ]
Huilaja, Laura [1 ,2 ]
Panelius, Jaana [3 ,4 ]
Tasanen, Kaisa [1 ,2 ]
Varpuluoma, Outi [1 ,2 ]
机构：
[1] Oulu Univ Hosp, Med Res Ctr Oulu, Dept Dermatol, Res Unit Clin Med, Aapistie 5 A, FIN-90220 Oulu, Finland
[2] Univ Oulu, Aapistie 5 A, Oulu 90220, Finland
[3] Univ Helsinki, Dept Dermatol & Allergol, Helsinki, Finland
[4] Helsinki Univ Hosp, Helsinki, Finland
[5] Univ Oulu, Infrastruct Populat Studies, Oulu, Finland
来源：
ACTA DERMATO-VENEREOLOGICA | 2024年 / 104卷
基金：
芬兰科学院;
关键词：
D O I：
10.2340/actadv.v104.40645
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Elevated parathyroid hormone is associated with an increased mortality risk in type 2 diabetes
    Muendlein, Axel
    Leiherer, Andreas
    Saely, Christoph H.
    Geiger, Kathrin
    Brantner, Eva-Maria
    Larcher, Barbara
    Mader, Arthur
    Ebner, Karl-Martin
    Fraunberger, Peter
    Kleber, Marcus
    Dressel, Alexander
    Maerz, Winfried
    Drexel, Heinz
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 355 - 355
  • [22] Elevated Parathyroid Hormone Is Associated with an Increased Mortality Risk in Type 2 Diabetes
    Muendlein, Axel
    Leiherer, Andreas
    Saely, Christoph H.
    Geiger, Kathrin
    Brandtner, Eva-Maria
    Larcher, Barbara
    Mader, Arthur
    Fraunberger, Peter
    Kleber, Marcus
    Dressel, Alexander
    Maerz, Winfried
    Drexel, Heinz
    DIABETES, 2018, 67
  • [23] Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatment
    Erika Paniago Guedes
    Alexandre Hohl
    Thais Gomes de Melo
    Felipe Lauand
    Diabetology & Metabolic Syndrome, 5
  • [24] Teneligliptin-associated bullous pemphigoid in an elderly man with diabetes
    Guliani, Ankur
    Bishnoi, Anuradha
    Aggarwal, Divya
    Parsad, Davinder
    POSTGRADUATE MEDICAL JOURNAL, 2018, 94 (1117) : 662 - 663
  • [25] Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment
    Bernard, Philippe
    Antonicelli, Frank
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2017, 18 (04) : 513 - 528
  • [26] Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment
    Philippe Bernard
    Frank Antonicelli
    American Journal of Clinical Dermatology, 2017, 18 : 513 - 528
  • [27] Genetic susceptibility of dipeptidyl Peptidase-4 inhibitor associated bullous pemphigoid in Chinese patients with type 2 diabetes
    Shi, Mai
    Yang, Aimin
    Chow, Elaine
    Lau, Eric S. H.
    Tam, Claudia H. T.
    Kong, Alice P. S.
    Luk, Andrea O. Y.
    Ma, Ronald C. W.
    Cheung, Christina M. T.
    Chan, Juliana C. N.
    Chan, Agnes W. S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (03) : E375 - E377
  • [28] Dulaglutide-related bullous pemphigoid in a patient with type 2 diabetes: A case report
    Fukuda, Gen
    Yoshida, Tomohiko
    Hirayama, Arisa
    Umezawa, Yoshinori
    Takemoto, Minoru
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2019, 19 (12) : 1289 - 1290
  • [29] Linagliptin approved for type 2 diabetes
    Traynor, Kate
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (12) : 1059 - 1059
  • [30] Linagliptin: An Update of Its Use in Patients with Type 2 Diabetes Mellitus
    Kate McKeage
    Drugs, 2014, 74 : 1927 - 1946
12345